Sk Biopharmaceuticals Co Ltd (326030) — Free Cash Flow Generation Index
Sk Biopharmaceuticals Co Ltd (326030) has a Free Cash Flow Generation Index of 0.84x as of March 2026. Free cash flow of ₩14.97 Billion represents 1% of operating cash flow (₩17.92 Billion). Explore 326030 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sk Biopharmaceuticals Co Ltd Free Cash Flow Generation Index (2024–2025)
Historical FCF Generation Index trend for Sk Biopharmaceuticals Co Ltd across 2 annual periods. For the full cash flow conversion analysis, see Sk Biopharmaceuticals Co Ltd cash flow conversion.
Annual Free Cash Flow Generation for Sk Biopharmaceuticals Co Ltd (2024–2025)
Year-by-year Free Cash Flow Generation Index for Sk Biopharmaceuticals Co Ltd. Check 326030 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.83x | ₩146.82 Billion | ₩176.33 Billion | ₩29.51 Billion | ▼ -3.0% |
| 2024 | 0.86x | ₩81.48 Billion | ₩94.90 Billion | ₩13.42 Billion | — |